Callitas Theraputics Inc., a wholly owned subsidiary of M Pharmaceutial Inc.

Privacy Policy

Privacy Policy 2017-07-29T07:36:04+00:00

Privacy policy

Privacy

Callitas Therapeutics an M-Pharmaceutical Inc. company collects personally identifying information about you only when you specifically and knowingly provide it to us.

We recognize that we need to earn your trust, and firmly believe that you should know exactly what personally identifying information we collect and how we are going to use it before you share it with us.

Basic statement

Personally identifying information that you provide to Callitas Therapeutics will not be made available to third parties outside Callitas Therapeutics without your explicit permission.

Callitas Therapeutics collects personally identifying information about you only when you specifically and knowingly provide it to us. Your personally identifying information will be used to personalize your experience with Callitas Therapeutics, or for such other purposes as are described at any point where Callitas Therapeutics collects this information from you.

Callitas Therapeutics may make aggregate information about our customers (e.g. overall statistics) available to third parties for advertising and other purposes. Information that personally identifies you will be kept strictly confidential.

Personally identifying information which you choose to provide to another party or web site will be subject to their privacy policy. For example, if you purchase goods or services from a merchant you found while browsing the Callitas Therapeutics web site, information you provide to that merchant is subject to their privacy policy, rather than ours.

What is personally identifying information?

“Personally identifying information” is information that can be explicitly used to identify and/or contact you as an individual. This includes information like your real name, email address, mailing address, phone number, credit card number, etc. Information that, by itself, cannot be explicitly linked with your “real” identity is not considered personally identifying. Examples of this are favorite or bookmarked web sites, or your preferences with respect to how you wish to see a given page or site set up according to the selections you choose.

Links to other sites

Users should be aware that when you are on the Callitas Therapeutics web site, you could be directed to other sites that are beyond our control. There are links to other sites from the Callitas Therapeutics web site pages that take you outside our service. This includes links from advertisers, sponsors and partners that may use the Callitas Therapeutics logo as part of a co-branding agreement.

The Callitas Therapeutics policy does not extend to anything that is inherent in the operation of the Internet, and therefore beyond Callitas Therapeutics’s control, and is not to be applied in any manner contrary to applicable law or governmental regulation.

Email to us

When you send email to Callitas Therapeutics, we will use your name and email address only to respond to the concerns you write to us with. Your email may be shared with appropriate people within the Callitas Therapeutics organization to help us respond to your concerns or questions.

Changes to this policy

From time to time, the Callitas Therapeutics web site may introduce new features and services. Callitas Therapeutics reserves the right to modify this policy at any time by notifying customers, via the Callitas Therapeutics web site, of a new privacy policy. You can send email to info@m-pharma.ca with any further questions.

 

Cautionary Statement

Forward Looking Statements

This website may contain forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe”, “aims”, “projects” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This website and the contents provided through links on the site include forward-looking statements with respect to the commercialization of the rights to Callitas Therapeutics’s biomedical techologies, including the achievement of certain milestones, and the acquisition of additional products. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com and such factors as the Company failing to identify and acquire additional technologies and the failure to complete the commercialization of of Callitas Therapeutics’s biomedical technologies.

Medical devices sold in Canada must comply with the Canadian Medical Device Regulations (“CDMR”).  Health Canada reviews medical devices to assess their safety, effectiveness and quality before being authorized for sale in Canada.  CMDR categorizes medical devices based on risk as Class I, II, III or IV.

The commercial development of Callitas Therapeutics’s biomedical technologies will require the successful coordination and execution of a wide variety of technology disciplines.

Private Policy

Callitas Therapeutics collects personally identifying information about you only when you specifically and knowingly provide it to us.

We recognize that we need to earn your trust, and firmly believe that you should know exactly what personally identifying information we collect and how we are going to use it before you share it with us.

Basic statement

Personally identifying information that you provide to Callitas Therapeutics will not be made available to third parties outside Callitas Therapeutics without your explicit permission.

Callitas Therapeutics collects personally identifying information about you only when you specifically and knowingly provide it to us. Your personally identifying information will be used to personalize your experience with Callitas Therapeutics, or for such other purposes as are described at any point where Callitas Therapeutics collects this information from you.

Callitas Therapeutics may make aggregate information about our customers (e.g. overall statistics) available to third parties for advertising and other purposes. Information that personally identifies you will be kept strictly confidential.

Personally identifying information which you choose to provide to another party or web site will be subject to their privacy policy. For example, if you purchase goods or services from a merchant you found while browsing the Callitas Therapeutics web site, information you provide to that merchant is subject to their privacy policy, rather than ours.

What is personally identifying information?

“Personally identifying information” is information that can be explicitly used to identify and/or contact you as an individual. This includes information like your real name, email address, mailing address, phone number, credit card number, etc. Information that, by itself, cannot be explicitly linked with your “real” identity is not considered personally identifying. Examples of this are favourite or bookmarked web sites, or your preferences with respect to how you wish to see a given page or site set up according to the selections you choose.

Links to other sites

Users should be aware that when you are on the Callitas Therapeutics web site, you could be directed to other sites that are beyond our control. There are links to other sites from the Callitas Therapeutics web site pages that take you outside our service. This includes links from advertisers, sponsors and partners that may use the Callitas Therapeutics logo as part of a co-branding agreement.

The Callitas Therapeutics policy does not extend to anything that is inherent in the operation of the Internet, and therefore beyond Callitas Therapeutics’s control, and is not to be applied in any manner contrary to applicable law or governmental regulation.

Email to us

When you send email to Callitas Therapeutics, we will use your name and email address only to respond to the concerns you write to us with. Your email may be shared with appropriate people within the Callitas Therapeutics organization to help us respond to your concerns or questions.

Changes to this policy

From time to time, the Callitas Therapeutics web site may introduce new features and services. Callitas Therapeutics reserves the right to modify this policy at any time by notifying customers, via the Callitas Therapeutics web site, of a new privacy policy. You can send email to info@m-pharma.ca with any further questions.

COMPANY INFO

  • 1.859.868.3131
  • 187 Pavilion Parkway
    Suite 200
    Newport, Kentucky 41071

PRESS AND MEDIA INQUIRIES